First Capital Advisors Group, Llc. Amphastar Pharmaceuticals, Inc. Transaction History
First Capital Advisors Group, Llc.
- $188 Million
- Q2 2023
A detailed history of First Capital Advisors Group, Llc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, First Capital Advisors Group, Llc. holds 42 shares of AMPH stock, worth $1,784. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42Holding current value
$1,784% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
33.4MCall Options Held
56.6KPut Options Held
57.3K-
Black Rock Inc. New York, NY6.08MShares$258 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$116 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.08MShares$88.2 Million0.21% of portfolio
-
Neuberger Berman Group LLC New York, NY1.66MShares$70.5 Million0.06% of portfolio
-
State Street Corp Boston, MA1.51MShares$64.3 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.08B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...